Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes
Concentric left ventricular (LV) remodeling is associated with adverse cardiovascular events and is frequently observed in patients with type 2 diabetes mellitus (T2DM). Despite this, the cause of concentric remodeling in diabetes per se is unclear, but it may be related to cardiac steatosis and imp...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Journal article |
| Լեզու: | English |
| Հրապարակվել է: |
American Diabetes Association
2015
|
| _version_ | 1826261386776281088 |
|---|---|
| author | Levelt, E Mahmod, M Piechnik, S Ariga, R Francis, J Rodgers, C Clarke, W Sabharwal, N Schneider, J Karamitsos, T Clarke, K Rider, O Neubauer, S |
| author_facet | Levelt, E Mahmod, M Piechnik, S Ariga, R Francis, J Rodgers, C Clarke, W Sabharwal, N Schneider, J Karamitsos, T Clarke, K Rider, O Neubauer, S |
| author_sort | Levelt, E |
| collection | OXFORD |
| description | Concentric left ventricular (LV) remodeling is associated with adverse cardiovascular events and is frequently observed in patients with type 2 diabetes mellitus (T2DM). Despite this, the cause of concentric remodeling in diabetes per se is unclear, but it may be related to cardiac steatosis and impaired myocardial energetics. Thus, we investigated the relationship between myocardial metabolic changes and LV remodeling in T2DM. Forty-six nonhypertensive patients with T2DM and 20 matched control subjects underwent cardiovascular magnetic resonance to assess LV remodeling (LV mass-to-LV end diastolic volume ratio), function, tissue characterization before and after contrast using T1 mapping, and (1)H and (31)P magnetic resonance spectroscopy for myocardial triglyceride content (MTG) and phosphocreatine-to-ATP ratio, respectively. When compared with BMI- and blood pressure-matched control subjects, subjects with diabetes were associated with concentric LV remodeling, higher MTG, impaired myocardial energetics, and impaired systolic strain indicating a subtle contractile dysfunction. Importantly, cardiac steatosis independently predicted concentric remodeling and systolic strain. Extracellular volume fraction was unchanged, indicating the absence of fibrosis. In conclusion, cardiac steatosis may contribute to concentric remodeling and contractile dysfunction of the LV in diabetes. Because cardiac steatosis is modifiable, strategies aimed at reducing MTG may be beneficial in reversing concentric remodeling and improving contractile function in the hearts of patients with diabetes. |
| first_indexed | 2024-03-06T19:20:36Z |
| format | Journal article |
| id | oxford-uuid:19f3e9ff-6d12-4ebe-aa60-cabf864d50dc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:20:36Z |
| publishDate | 2015 |
| publisher | American Diabetes Association |
| record_format | dspace |
| spelling | oxford-uuid:19f3e9ff-6d12-4ebe-aa60-cabf864d50dc2022-03-26T10:52:01ZRelationship between left ventricular structural and metabolic remodeling in type 2 diabetesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:19f3e9ff-6d12-4ebe-aa60-cabf864d50dcEnglishSymplectic Elements at OxfordAmerican Diabetes Association2015Levelt, EMahmod, MPiechnik, SAriga, RFrancis, JRodgers, CClarke, WSabharwal, NSchneider, JKaramitsos, TClarke, KRider, ONeubauer, SConcentric left ventricular (LV) remodeling is associated with adverse cardiovascular events and is frequently observed in patients with type 2 diabetes mellitus (T2DM). Despite this, the cause of concentric remodeling in diabetes per se is unclear, but it may be related to cardiac steatosis and impaired myocardial energetics. Thus, we investigated the relationship between myocardial metabolic changes and LV remodeling in T2DM. Forty-six nonhypertensive patients with T2DM and 20 matched control subjects underwent cardiovascular magnetic resonance to assess LV remodeling (LV mass-to-LV end diastolic volume ratio), function, tissue characterization before and after contrast using T1 mapping, and (1)H and (31)P magnetic resonance spectroscopy for myocardial triglyceride content (MTG) and phosphocreatine-to-ATP ratio, respectively. When compared with BMI- and blood pressure-matched control subjects, subjects with diabetes were associated with concentric LV remodeling, higher MTG, impaired myocardial energetics, and impaired systolic strain indicating a subtle contractile dysfunction. Importantly, cardiac steatosis independently predicted concentric remodeling and systolic strain. Extracellular volume fraction was unchanged, indicating the absence of fibrosis. In conclusion, cardiac steatosis may contribute to concentric remodeling and contractile dysfunction of the LV in diabetes. Because cardiac steatosis is modifiable, strategies aimed at reducing MTG may be beneficial in reversing concentric remodeling and improving contractile function in the hearts of patients with diabetes. |
| spellingShingle | Levelt, E Mahmod, M Piechnik, S Ariga, R Francis, J Rodgers, C Clarke, W Sabharwal, N Schneider, J Karamitsos, T Clarke, K Rider, O Neubauer, S Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| title | Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| title_full | Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| title_fullStr | Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| title_full_unstemmed | Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| title_short | Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| title_sort | relationship between left ventricular structural and metabolic remodeling in type 2 diabetes |
| work_keys_str_mv | AT levelte relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT mahmodm relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT piechniks relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT arigar relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT francisj relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT rodgersc relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT clarkew relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT sabharwaln relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT schneiderj relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT karamitsost relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT clarkek relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT ridero relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes AT neubauers relationshipbetweenleftventricularstructuralandmetabolicremodelingintype2diabetes |